BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 26797355)

  • 1. Differentiating Mass-Forming Autoimmune Pancreatitis From Pancreatic Ductal Adenocarcinoma on the Basis of Contrast-Enhanced MRI and DWI Findings.
    Choi SY; Kim SH; Kang TW; Song KD; Park HJ; Choi YH
    AJR Am J Roentgenol; 2016 Feb; 206(2):291-300. PubMed ID: 26797355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multimodel magnetic resonance imaging of mass-forming autoimmune pancreatitis: differential diagnosis with pancreatic ductal adenocarcinoma.
    Jia H; Li J; Huang W; Lin G
    BMC Med Imaging; 2021 Oct; 21(1):149. PubMed ID: 34654379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic duct "Icicle sign" on MRI for distinguishing autoimmune pancreatitis from pancreatic ductal adenocarcinoma in the proximal pancreas.
    Kim HJ; Kim YK; Jeong WK; Lee WJ; Choi D
    Eur Radiol; 2015 Jun; 25(6):1551-60. PubMed ID: 25501271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mass-forming autoimmune pancreatitis and pancreatic carcinoma: differential diagnosis on the basis of computed tomography and magnetic resonance cholangiopancreatography, and diffusion-weighted imaging findings.
    Muhi A; Ichikawa T; Motosugi U; Sou H; Sano K; Tsukamoto T; Fatima Z; Araki T
    J Magn Reson Imaging; 2012 Apr; 35(4):827-36. PubMed ID: 22069025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of diagnostic performance between CT and MRI in differentiating non-diffuse-type autoimmune pancreatitis from pancreatic ductal adenocarcinoma.
    Lee S; Kim JH; Kim SY; Byun JH; Kim HJ; Kim MH; Lee MG; Lee SS
    Eur Radiol; 2018 Dec; 28(12):5267-5274. PubMed ID: 29948075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of non-contrast MR imaging in distinguishing pancreatic ductal adenocarcinoma from focal pancreatitis.
    Lee JH; Min JH; Kim YK; Cha DI; Lee J; Park HJ; Ahn S
    Clin Imaging; 2019; 55():132-139. PubMed ID: 30818163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance imaging findings of the mass-forming type of autoimmune pancreatitis: comparison with pancreatic adenocarcinoma.
    Hur BY; Lee JM; Lee JE; Park JY; Kim SJ; Joo I; Shin CI; Baek JH; Kim JH; Han JK; Choi BI
    J Magn Reson Imaging; 2012 Jul; 36(1):188-97. PubMed ID: 22371378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI features for differentiation of autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A systematic review and meta-analysis.
    Ha J; Choi SH; Kim KW; Kim JH; Kim HJ
    Dig Liver Dis; 2022 Jul; 54(7):849-856. PubMed ID: 34903501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Focal pancreatitis mimicking pancreatic mass: magnetic resonance imaging (MRI)/magnetic resonance cholangiopancreatography (MRCP) findings including diffusion-weighted MRI.
    Momtahen AJ; Balci NC; Alkaade S; Akduman EI; Burton FR
    Acta Radiol; 2008 Jun; 49(5):490-7. PubMed ID: 18568532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of magnetic resonance elastography in differentiating autoimmune pancreatitis from pancreatic ductal adenocarcinoma: A preliminary study.
    Shi Y; Cang L; Zhang X; Cai X; Wang X; Ji R; Wang M; Hong Y
    Eur J Radiol; 2018 Nov; 108():13-20. PubMed ID: 30396645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differentiating focal autoimmune pancreatitis and pancreatic ductal adenocarcinoma: contrast-enhanced MRI with special emphasis on the arterial phase.
    Kwon JH; Kim JH; Kim SY; Byun JH; Kim HJ; Lee MG; Lee SS
    Eur Radiol; 2019 Nov; 29(11):5763-5771. PubMed ID: 31028441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of apparent diffusion coefficient value in the diagnosis of localized type 1 autoimmune pancreatitis: differentiation from pancreatic ductal adenocarcinoma and evaluation of response to steroids.
    Sekito T; Ishii Y; Serikawa M; Tsuboi T; Kawamura R; Tsushima K; Nakamura S; Hirano T; Fukiage A; Mori T; Ikemoto J; Kiyoshita Y; Saeki S; Tamura Y; Miyamoto S; Chayama K
    Abdom Radiol (NY); 2021 May; 46(5):2014-2024. PubMed ID: 33386451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging.
    Guo C; Chen X; Wang Z; Xiao W; Wang Q; Sun K; Zhuge X
    Oncotarget; 2017 Jun; 8(26):42962-42973. PubMed ID: 28487490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differentiation of autoimmune pancreatitis from pancreatic cancer by diffusion-weighted MRI.
    Kamisawa T; Takuma K; Anjiki H; Egawa N; Hata T; Kurata M; Honda G; Tsuruta K; Suzuki M; Kamata N; Sasaki T
    Am J Gastroenterol; 2010 Aug; 105(8):1870-5. PubMed ID: 20216538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic review and meta-analysis of MRI features for differentiating autoimmune pancreatitis from pancreatic adenocarcinoma.
    Yoon SB; Jeon TY; Moon SH; Lee SM; Kim MH
    Eur Radiol; 2022 Oct; 32(10):6691-6701. PubMed ID: 35486167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune pancreatitis: imaging findings on contrast-enhanced MR, MRCP and dynamic secretin-enhanced MRCP.
    Carbognin G; Girardi V; Biasiutti C; Camera L; Manfredi R; Frulloni L; Hermans JJ; Mucelli RP
    Radiol Med; 2009 Dec; 114(8):1214-31. PubMed ID: 19789959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DWI findings of autoimmune pancreatitis: comparison between symptomatic and asymptomatic patients.
    Oki H; Hayashida Y; Oki H; Kakeda S; Aoki T; Taguchi M; Harada M; Korogi Y
    J Magn Reson Imaging; 2015 Jan; 41(1):125-31. PubMed ID: 24273124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective apparent diffusion coefficient parameters for differentiation between mass-forming autoimmune pancreatitis and pancreatic ductal adenocarcinoma.
    Ren H; Mori N; Hamada S; Takasawa C; Mugikura S; Masamune A; Takase K
    Abdom Radiol (NY); 2021 Apr; 46(4):1640-1647. PubMed ID: 33037891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of autoimmune pancreatitis from pancreatic adenocarcinoma using CT characteristics: a systematic review and meta-analysis.
    Yoon SB; Jeon TY; Moon SH; Shin DW; Lee SM; Choi MH; Min JH; Kim MJ
    Eur Radiol; 2023 Dec; 33(12):9010-9021. PubMed ID: 37466708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis and treatment of autoimmune pancreatitis types 1 and 2.
    Fritz S; Bergmann F; Grenacher L; Sgroi M; Hinz U; Hackert T; Büchler MW; Werner J
    Br J Surg; 2014 Sep; 101(10):1257-65. PubMed ID: 25047016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.